source Post navigation ACC 2025: GLP-1RAs may reduce incidence of AF/flutter and stroke in diabetic patients – Pharmaceutical Technology Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India – Nature